1 |
activator protein-1
(3953 times)
|
Biochemistry (748 times)
|
NF-kappaB (1023 times) JNK (358 times) MAPK (318 times)
|
1987 Upstream regulatory regions required to stabilize binding to the TATA sequence in an adenovirus early promoter.
|
2 |
adaptor protein 1
(47 times)
|
Cell Biology (11 times)
|
TGN (9 times) CCVs (3 times) MHC-I (3 times)
|
1998 Different domains of mammalian ADP-ribosylation factor 1 mediate interaction with selected target proteins.
|
3 |
adaptor protein complex 1
(43 times)
|
Cell Biology (11 times)
|
TGN (10 times) CCV (2 times) GGAs (2 times)
|
1998 The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.
|
4 |
activator protein-1 transcription factor complex
(7 times)
|
Biology (3 times)
|
MAPK (2 times) TH (2 times) Afos (1 time)
|
1997 Aberrant expression of c-Fos accompanies photoreceptor cell death in the rd mouse.
|
5 |
factor-activated protein-1
(7 times)
|
Neoplasms (3 times)
|
CDDP (1 time) CsA (1 time) EMSA (1 time)
|
1995 Effects of single cyclosporin A pretreatment on pentylenetetrazol-induced convulsion and on TRE-binding activity in the rat brain.
|
6 |
atherosclerotic plaque-specific peptide-1
(6 times)
|
Medicine (1 time)
|
GBM (3 times) BBB (2 times) FUS (2 times)
|
2012 Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound.
|
7 |
adaptor complex 1
(5 times)
|
Biochemistry (2 times)
|
GGA (2 times) TGN (2 times) AP-2 (1 time)
|
2003 Involvement of the AP-1 adaptor complex in early steps of phagocytosis and macropinocytosis.
|
8 |
AP-1-like sites, and activated by the Fos/Jun heterodimeric complex
(3 times)
|
Biochemistry (2 times)
|
GST (2 times) MAP (1 time) MC (1 time)
|
1994 Intracellular glutathione levels regulate Fos/Jun induction and activation of glutathione S-transferase gene expression.
|
9 |
acting transcription factor-1
(2 times)
|
Virology (1 time)
|
CI (1 time) HBV (1 time) IFN-gamma (1 time)
|
2002 Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells.
|
10 |
activator protein-1 complex
(2 times)
|
Molecular Biology (1 time)
|
ERRalpha (1 time) PGC-1alpha (1 time) TFBSs (1 time)
|
1999 Increased AP-1 DNA binding activity in PC12 cells treated with lead.
|
11 |
adaptor-related protein complex 1
(2 times)
|
Allergy and Immunology (1 time)
|
Bcl11b (1 time) GATA3 (1 time) Id3 (1 time)
|
2011 Transcriptional control of T-cell development.
|
12 |
arsenoplatin-1
(2 times)
|
Chemistry (2 times)
|
---
|
2019 Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent.
|
13 |
Actinobacillus pleuropneumoniae serotype 1
(1 time)
|
Veterinary Medicine (1 time)
|
CFU (1 time)
|
2003 Oral immunization using formalin-inactivated Actinobacillus pleuropneumoniae antigens entrapped in microspheres with aqueous dispersion polymers prepared using a co-spray drying process.
|
14 |
activating protein complex 1
(1 time)
|
Biochemistry (1 time)
|
IL-1 (1 time)
|
1996 Transcriptional downregulation of stromelysin by tetracycline.
|
15 |
activator binding protein-1
(1 time)
|
Biochemistry (1 time)
|
C/EBP (1 time) COX-2 (1 time) CRE-2 (1 time)
|
2008 Cyclooxygenase-2 expression induced by photofrin photodynamic therapy involves the p38 MAPK pathway.
|
16 |
activator of transcription 1
(1 time)
|
Allergy and Immunology (1 time)
|
CNS (1 time) COX (1 time) IL (1 time)
|
2015 Design, synthesis and evaluation of a series of non-steroidal anti-inflammatory drug conjugates as novel neuroinflammatory inhibitors.
|
17 |
activator protein 1 binding motif
(1 time)
|
Pharmacokinetics (1 time)
|
CAR (1 time) CLEM (1 time) Evi1 (1 time)
|
2015 A CAR-responsive enhancer element locating approximately 31 kb upstream in the 5'-flanking region of rat cytochrome P450 (CYP) 3A1 gene.
|
18 |
activator protein 1 proteins
(1 time)
|
Dermatology (1 time)
|
DRF-1 (1 time) MMP-9 (1 time) TRE (1 time)
|
2004 Matrix metalloproteinase 9 expression is coordinately modulated by the KRE-M9 and 12-O-tetradecanoyl-phorbol-13-acetate responsive elements.
|
19 |
activator protein 1 responsive element
(1 time)
|
Endocrinology (1 time)
|
CRE (1 time) CRF (1 time) CRFR1 (1 time)
|
2007 Expression of molecular equivalent of hypothalamic-pituitary-adrenal axis in adult retinal pigment epithelium.
|
20 |
Activator Protein-1 DNA-binding
(1 time)
|
Biochemistry (1 time)
|
ER (1 time) IKK (1 time) NF-kappaB (1 time)
|
2005 Activation of nuclear factor-kappaB (NFkappaB) identifies a high-risk subset of hormone-dependent breast cancers.
|
21 |
Activator Protein-1 site
(1 time)
|
Chemistry (1 time)
|
---
|
2006 Regulation of the mouse Na+-dependent glutamate/aspartate transporter GLAST: putative role of an AP-1 DNA binding site.
|
22 |
adaptin-1
(1 time)
|
Microbiology (1 time)
|
DUBs (1 time)
|
2015 Modulation of the Surface Proteome through Multiple Ubiquitylation Pathways in African Trypanosomes.
|
23 |
adaptor 1
(1 time)
|
Genetics (1 time)
|
GGA (1 time) PM (1 time)
|
2016 Traffic Through the Trans-Golgi Network and the Endosomal System Requires Collaboration Between Exomer and Clathrin Adaptors in Fission Yeast.
|
24 |
affected the RIP1-NF-kappaB/c-jun
(1 time)
|
Biochemistry (1 time)
|
RIP (1 time)
|
2014 Expression of the RIP-1 gene and its role in growth and invasion of human gallbladder carcinoma.
|
25 |
aminopeptidase-1
(1 time)
|
Biochemistry (1 time)
|
LTA4 (1 time)
|
1998 Molecular cloning and functional expression of a Caenorhabditis elegans aminopeptidase structurally related to mammalian leukotriene A4 hydrolases.
|
26 |
angiopoietin-1
(1 time)
|
Perinatology (1 time)
|
BPD (1 time) PAH (1 time)
|
2014 Serial changes of serum endostatin and angiopoietin-1 levels in preterm infants with severe bronchopulmonary dysplasia and subsequent pulmonary artery hypertension.
|
27 |
ap response element
(1 time)
|
Biomedical Engineering (1 time)
|
---
|
2014 Two transaldolase isogenes from Moniliella megachiliensis behave in a different way depending on the stress class.
|
28 |
AP-1 and NF-kappaB are activated by 7,8-dihydroneopterin, either directly
(1 time)
|
Acquired Immunodeficiency Syndrome (1 time)
|
---
|
1997 trans-Activation of the HIV type 1 promoter by 7,8-dihydroneopterin in vitro.
|
29 |
AP-1 transcription factor subunit
(1 time)
|
Biochemistry (1 time)
|
alpha-SMA (1 time) IPF (1 time) miRs (1 time)
|
2019 MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis.
|
30 |
AP-1, GenBank accession No. JQ824201.1
(1 time)
|
Natural Science Disciplines (1 time)
|
BmCPV (1 time)
|
2018 Clathrin-mediated endocytosis is a candidate entry sorting mechanism for Bombyx mori cypovirus.
|
31 |
AP-1-responsive gene
(1 time)
|
Biochemistry (1 time)
|
---
|
1993 Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis.
|
32 |
apolipoprotein-1
(1 time)
|
Rheumatology (1 time)
|
EGCG (1 time) MAPK (1 time) NF-kappaB (1 time)
|
2005 Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
|
33 |
aptamer 1
(1 time)
|
Cardiology (1 time)
|
AP-2 (1 time) CE-SELEX (1 time) LDL (1 time)
|
2020 Single-Strand DNA-Like Oligonucleotide Aptamer Against Proprotein Convertase Subtilisin/Kexin 9 Using CE-SELEX: PCSK9 Targeting Selection.
|
34 |
assembly protein-1
(1 time)
|
Science (1 time)
|
PtdIns4P (1 time) TGN (1 time)
|
2017 Conserved role for Gga proteins in phosphatidylinositol 4-kinase localization to the trans-Golgi network.
|
35 |
MRTF-A was recruited to the ET-1 promoter by c-Jun/c-Fos
(1 time)
|
Cardiology (1 time)
|
Ang II (1 time) MRTF-A (1 time)
|
2014 Endothelial MRTF-A mediates angiotensin II induced cardiac hypertrophy.
|
36 |
protein-1 activators
(1 time)
|
Biochemistry (1 time)
|
CAPE (1 time) DHE (1 time) JNK (1 time)
|
2018 Anti-osteoclastic effect of caffeic acid phenethyl ester in murine macrophages depends upon the suppression of superoxide anion production through the prevention of an active-Nox1 complex formation.
|